Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation

  • Khoury Damaa, Michella
  • Gil Gómez, Gabriel
  • Meunier, Alice
Multiciliated cells (MCCs) ensure fluid circulation in various organs. Their differentiation is marked by the amplification of cilia-nucleating centrioles, driven by a genuine cell-cycle variant, which is characterized by wave-like expression of canonical and non-canonical cyclins such as Cyclin O (CCNO). Patients with CCNO mutations exhibit a subtype of primary ciliary dyskinesia called reduced generation of motile cilia (RGMC). Here, we show that Ccno is activated at the crossroads of the onset of MCC differentiation, the entry into the MCC cell-cycle variant, and the activation of the centriole biogenesis program. Its absence blocks the G1/S-like transition of the cell-cycle variant, interrupts the centriologenesis transcription program, and compromises the production of centrioles and cilia in mouse brain and human respiratory MCCs. Altogether, our study identifies CCNO as a core regulator of entry into the MCC cell-cycle variant and the interruption of this variant as one etiology of RGMC., This work is supported by funding to A.M. from the ANR (ANR-19-CE13-0027) and Q-life Program. The Spassky lab is also funded by Inserm, the CNRS, the École Normale Supérieure, the ANR (ANR-20-CE45-0019, ANR-21-CE16-0016, ANR-22-CE16-0011), the European Research Council (ERC grant agreement 647466), and the Fondation pour la Recherche Médicale (FRM, EQU 202103012767). The Roy lab is supported by the Agency for Science, Technology and Research (A∗STAR) and a National Medical Research Council of Singapore grant (OFIRG19nov-0037). R.K. is supported by the Institut Pasteur, CNRS, and the European Research Council (ERC grant agreement 771813); J.S. is funded by the Association pour la Recherche sur le Cancer; M.K.D. is funded by the FRM; A.-R.B. is funded by La Ligue Contre Le Cancer; C.T.J. was supported by an A∗STAR Research Attachment Program (ARAP) fellowship; and S.J.A. is supported by the German Research Foundation through a Heisenberg Professorship (AR 732/3-1), project P7 of SFB 1453 (project ID 431984000) and Germany's Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984). This work was performed with support from the National Infrastructure France Génomique (Commissariat aux Grands Investissements, ANR-10-INBS-09-03, ANR-10-INBS-09-02), the 3IA Côte d’Azur (ANR-19-P3IA-0002), European Union’s H2020 Research and Innovation Program under grant agreement no. 874656 (discovAIR), and Conseil départemental 06 (2016-294DGADSH-CV).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell culture differentiation and proliferation conditions influence thein vitroregeneration of the human airway epithelium

  • Redman, Elisa
  • Fierville, Morgane
  • Cavard, Amélie
  • Plaisant, Magali
  • Arguel, Marie-Jeanne
  • Ruiz Garcia, Sandra
  • McAndrew, Eamon M.
  • Girard-Riboulleau, Cédric
  • Lebrigand, Kevin
  • Magnone, Virginie
  • Ponzio, Gilles
  • Gras, Delphine
  • Chanez, Pascal
  • Abelanet, Sophie
  • Barbry, Pascal
  • Marcet, Brice
  • Zaragosi, Laure-Emmanuelle
The human airway mucociliary epithelium can be recapitulated in vitro using primary cells cultured in an air-liquid interface (ALI), a reliable surrogate to perform pathophysiological studies. As tremendous variations exist among media used for ALI-cultured human airway epithelial cells, the aim of our study was to evaluate the impact of several media (BEGM, PneumaCult, Half & Half, and Clancy) on cell type distribution using single-cell RNA sequencing and imaging. Our work revealed the impact of these media on cell composition, gene expression profile, cell signaling, and epithelial morphology. We found higher proportions of multiciliated cells in PneumaCult-ALI and Half & Half, stronger EGF signaling from basal cells in BEGM-ALI, differential expression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry factor ACE2, and distinct secretome transcripts depending on the media used. We also established that proliferation in PneumaCult-Ex Plus favored secretory cell fate, showing the key influence of proliferation media on late differentiation epithelial characteristics. Altogether, our data offer a comprehensive repertoire for evaluating the effects of culture conditions on airway epithelial differentiation and will aid in choosing the most relevant medium according to the processes to be investigated, such as cilia, mucus biology, or viral infection. We detail useful parameters that should be explored to document airway epithelial cell fate and morphology., Supported by Fondation pour la Recherche Medicale grant DEQ20180339158; Institut National de la Sante et de la Recherche Medicale Inserm Cross-Cutting Scientific Program HuDeCA 201; Chan Zuckerberg Initiative grant 2017-175159-5022; H2020 Health DiscovAIR; Cancerop^ ole PACA Innovation Technologique 2018; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche grant 21-ESRE-0052, ANR-19-P3IA-0002, ANR-19-CE14-0027, ANR-23-IAHU-0007, ANR-10-INBS-09-02, ANR-10-INBS-09-03; and HORIZON EUROPE Marie Sklodowska-Curie Actions grant 101072892. Conseil Departemental 06 016-294DGADSH-CV; Fondation du Souffle., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation

  • Khoury Damaa, Michella
  • Gil Gómez, Gabriel
  • Meunier, Alice
Multiciliated cells (MCCs) ensure fluid circulation in various organs. Their differentiation is marked by the amplification of cilia-nucleating centrioles, driven by a genuine cell-cycle variant, which is characterized by wave-like expression of canonical and non-canonical cyclins such as Cyclin O (CCNO). Patients with CCNO mutations exhibit a subtype of primary ciliary dyskinesia called reduced generation of motile cilia (RGMC). Here, we show that Ccno is activated at the crossroads of the onset of MCC differentiation, the entry into the MCC cell-cycle variant, and the activation of the centriole biogenesis program. Its absence blocks the G1/S-like transition of the cell-cycle variant, interrupts the centriologenesis transcription program, and compromises the production of centrioles and cilia in mouse brain and human respiratory MCCs. Altogether, our study identifies CCNO as a core regulator of entry into the MCC cell-cycle variant and the interruption of this variant as one etiology of RGMC., This work is supported by funding to A.M. from the ANR (ANR-19-CE13-0027) and Q-life Program. The Spassky lab is also funded by Inserm, the CNRS, the École Normale Supérieure, the ANR (ANR-20-CE45-0019, ANR-21-CE16-0016, ANR-22-CE16-0011), the European Research Council (ERC grant agreement 647466), and the Fondation pour la Recherche Médicale (FRM, EQU 202103012767). The Roy lab is supported by the Agency for Science, Technology and Research (A∗STAR) and a National Medical Research Council of Singapore grant (OFIRG19nov-0037). R.K. is supported by the Institut Pasteur, CNRS, and the European Research Council (ERC grant agreement 771813); J.S. is funded by the Association pour la Recherche sur le Cancer; M.K.D. is funded by the FRM; A.-R.B. is funded by La Ligue Contre Le Cancer; C.T.J. was supported by an A∗STAR Research Attachment Program (ARAP) fellowship; and S.J.A. is supported by the German Research Foundation through a Heisenberg Professorship (AR 732/3-1), project P7 of SFB 1453 (project ID 431984000) and Germany's Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984). This work was performed with support from the National Infrastructure France Génomique (Commissariat aux Grands Investissements, ANR-10-INBS-09-03, ANR-10-INBS-09-02), the 3IA Côte d’Azur (ANR-19-P3IA-0002), European Union’s H2020 Research and Innovation Program under grant agreement no. 874656 (discovAIR), and Conseil départemental 06 (2016-294DGADSH-CV).